Podcasts

Electronic submission offers benefits for pharma, says ISI

Electronic submission offers benefits for pharma, says ISI

By Gareth Macdonald

Drug firms continue to make basic errors in their electronic submissions according to French regulatory group the AFSSAPS, which said recently that it returns half the NeeS dossiers it receives as they do not meet basic validation standards.

Informex – companies hope for a brighter 2010

Informex – companies hope for a brighter 2010

By Nick Taylor

There are signs that 2010 will be a better year for the fine and custom chemistry industry but companies at Informex remained cautious and are planning accordingly.

SAFC building big pharma relationships to drive growth

SAFC building big pharma relationships to drive growth

By Nick Taylor

The impact of the economic downturn is still being felt but SAFC remains "cautiously optimistic" about 2010, believing its close relationships with clients and investment in key emerging markets will generate business.

MENA emerging as trial destination says ClinTec CEO

MENA emerging as trial destination says ClinTec CEO

By Gareth Macdonald

Improving healthcare infrastructure across the region and a large treatment-naïve patient population makes the Middle East and North Africa (MENA) an increasingly attractive destination for drug trials says ClinTec CEO Rabinder Buttar.

AAPS - round up of day one

AAPS - round up of day one

By Nick Taylor

Following the first full day of AAPS 2009 in Los Angeles, California, US we take a look at the major developments and talking points.

CPhI 2009 - Road to recovery?

CPhI 2009 - Road to recovery?

By Nick Taylor

As CPhI 2009 draws to a close we take a look back on the show, which, despite some negatives, appears to have been an overall success.